Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Stem cell transplantation shows therapeutic effects post-myocardial infarction (MI), likely via paracrine factors.
• Stimulating vascular repair is crucial for treating ischemic heart disease.
• Mesenchymal stem cell (MSC) secretions are being investigated for their angiogenic potential.

Purpose of the Study:

• To explore the therapeutic angiogenic potential of mesenchymal stem cell (MSC) secretions.
• To assess the efficacy of MSC-conditioned medium (MSC-CM) in a preclinical model of myocardial infarction.

Main Methods:

• Human MSC secretions were collected as conditioned medium (MSC-CM).
• Proteomic and pathway analysis of MSC-CM was performed.
• In vitro HUVEC spheroid assay identified angiogenic properties.
• Pigs underwent surgical coronary artery ligation and received intravenous MSC-CM or non-CM treatment.

Main Results:

• MSC-CM treatment significantly increased myocardial capillary density in pigs post-MI (P = 0.021).
• MSC-CM administration reduced myocardial infarct size.
• Cardiac systolic and diastolic performance was preserved in the MSC-CM treatment group.

Conclusions:

• Intravenous MSC-CM treatment after myocardial infarction enhances capillary density and preserves cardiac function.
• MSC-CM likely improves cardiac function by increasing myocardial perfusion.
• MSC secretions represent a promising cell-free therapeutic strategy for ischemic heart disease.